Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
about
Engineering humoral immunity as prophylaxis or therapyThe Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein.Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDTGenetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in MiceNovel therapy based on camelid nanobodies.State of play and clinical prospects of antibody gene transfer.Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.Recombinant Lactobacillus plantarum expressing HA2 antigen elicits protective immunity against H9N2 avian influenza virus in chickens.Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.Single-Domain Antibodies As Therapeutics against Human Viral Diseases.
P2860
Q26800101-CC07C3FE-C066-4477-BFB9-588DC733B30CQ30387177-13970D59-EF2E-407A-A030-F7621F5B4D82Q33418526-413D75A5-A8DD-4432-BAE6-F4CE105D33F7Q34110625-A0238C4C-4249-4ECB-A12C-9861D5FEF096Q35544342-39934822-95FF-48EA-A2C9-A36E6ED45D40Q35952105-17C4FD22-5F11-4663-BD26-779D34457415Q36665638-6001237E-D713-46DB-BB5F-27E79A54879DQ38151739-F739A2EC-C79B-4B07-B204-D305C4816829Q38737706-94A75605-A6FF-455C-882A-4A918B2B9048Q40040079-77E3165A-908D-41E6-BF13-FDA14AEB6EB4Q41875163-EFFCA3F6-FDA0-4D20-9C10-472167189842Q45325437-E1CD23EB-F2E4-4FAC-BEE3-D346640A7103Q47548294-808B1B1F-CC51-4F83-8AC8-A5D310CEBF9EQ47554821-915F7E34-AD89-4D28-8D0F-F0DCF9D39A4D
P2860
Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Passive immunization with a re ...... om lethal influenza infection.
@ast
Passive immunization with a re ...... om lethal influenza infection.
@en
type
label
Passive immunization with a re ...... om lethal influenza infection.
@ast
Passive immunization with a re ...... om lethal influenza infection.
@en
prefLabel
Passive immunization with a re ...... om lethal influenza infection.
@ast
Passive immunization with a re ...... om lethal influenza infection.
@en
P2093
P921
P1433
P1476
Passive immunization with a re ...... rom lethal influenza infection
@en
P2093
Alexander L Gintsburg
Boris S Naroditsky
Denis Y Logunov
Elena S Sedova
Irina L Tutykhina
Irina Y Gribova
Lev A Vasilev
Marina V Rutovskaya
Maxim M Shmarov
Sergei V Tillib
P304
P356
10.1016/J.ANTIVIRAL.2012.12.021
P577
2012-12-26T00:00:00Z